Patent · US Active

Human CD163 antibodies and uses thereof

US11827715B2 · kind B2 · utility

1Cited by

19References

29Claims

0Family size

Assignee

OncoResponse, Inc. · US

Inventors

Kamal D. Puri · Seattle, US
Siddarth Chandrasekaran · Issaquah, US
Melissa L. Conerly · Seattle, US
Randi M. Simmons · Seattle, US
Tyrel T. Smith · Seattle, US
Mark Branum · Bellevue, US
Peter Probst · Seattle, US

Key dates

Filing date	Apr 22, 2021
Grant date	Nov 28, 2023
Priority date	—
Expiry date	Sep 29, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are antibodies and methods of use thereof. The antibodies as disclosed herein bind to CD163+ on cells, such as on macrophages. These antibodies can be used in methods of treatment, such as methods of treating cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.